Titlebook: Ethics of Innovation in Neurosurgery; Marike L. D. Broekman Book 2019 Springer Nature Switzerland AG 2019 Surgical innovation.Research eth

外向者

The Ethics of the Learning Curve in Innovative Neurosurgeryin complications, while neurosurgeons master both the procedure and the associated perioperative care. Balancing these potential risks of complications with potential benefits poses several challenges that warrant further examination. This chapter will discuss ethical management of learning curves,

ear-canal

Innovation in Pediatric Neurosurgery: The Ethical Agendaevelopment of medicine and has finally provided us with all the benefits of medical treatment for patients today. As a physician it is our moral duty to weigh the balance between potential harm and benefits before deciding to any treatment in an individual patient. An elementary aspect of an innovat

GRAIN

Conflicts of Interest in Neurosurgical Innovationnnovation and collaboration, as these same collaborative ventures are imperative for the advancement of any field. While neurosurgical innovation benefits from the vast collaboration, industry funding, and incentives for innovation, it is important that COI are managed ethically. Financial COI betwe

石墨

The Ethics of Funding Innovation: Who Should Pay?ovation in particular can cost millions of dollars for the development of new therapies. In the United States, the private sector is by far the largest annual funder of medical research (over $100 billion), with the federal government ($36 billion) contributing less than half as much as private comp

offense

Panacea

Surgical Innovation for Terminal Illnesses: Do Patients Have a Right to Access Innovative Treatmentscessarily be applied directly to innovation in surgery. It is sometimes considered difficult to meet the high ethical and regulatory standards for medical treatments in a surgical setting, where innovation is constantly occurring in small and incremental ways. Moving from these arguments, many have

MENT

情节剧

Evaluating Awake Craniotomies in Glioma Patients: Meeting the Challengeeveral questions regarding its efficacy and risks remain to be elucidated. This poses a challenge to the neurosurgical community, as the use of large randomized trials may be infeasible. The Institute of Medicine has recently introduced the ., a system that aims to facilitate continuous learning act

废除

Parley